(firstQuint)Reduction of Adverse Drug Events and Readmissions.

 Pharmocogenomic.

 A multicenter, observational study to evaluate the use of a Pharmocogenomic test assessment in the medication regimen and disease management for patients under drugs known to be influenced by genetic variation.

.

 Reduction of Adverse Drug Events and Readmissions@highlight

Pharmocogenomic test assessment in the medication regimen and disease management for patients under drugs known with genetic variation.

